Industrial production method of Alogliptin benzoate

Inactive Publication Date: 2019-01-18
NANHAI PHARMA CHONGQING
View PDF11 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although the patent claims to be an industrialized production method, it is actually produced in small doses of grams or milliliters, and the steps are many and complicated. Although the yield of

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Industrial production method of Alogliptin benzoate
  • Industrial production method of Alogliptin benzoate
  • Industrial production method of Alogliptin benzoate

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0050] The industrial production method of alogliptin benzoate of the present invention comprises three major steps, the first step prepares alogliptin intermediate AGⅠ, the second step prepares alogliptin intermediate AGII, and the third step prepares alogliptin benzoate Ting; the specific method is as follows.

[0051] The first step is to prepare the alogliptin intermediate AGI.

[0052](1) Add 24.5kg of N-methylpyrrolidone, 8.0kg of 6-chloro-3-methyluracil and 7.18kg of N,N-diisopropylethylamine into a 300L glass-lined reactor, and stir until dissolved.

[0053] (2) Add 8.16 kg of 2-cyanobenzyl bromide into the reaction kettle, and stir to dissolve.

[0054] (3) Heat the reaction kettle to 60-65°C, stir and keep warm for 3 hours; start TLC monitoring after 3 hours until the reaction ends, that is, the raw material point of 6-chloro-3-methyluracil basically disappears; take samples for monitoring every 0.5 hours.

[0055] The reaction endpoint monitoring method is as foll...

Embodiment 2

[0108] The first step is to prepare the alogliptin intermediate AGI.

[0109] (1) Add 36.75kg of N-methylpyrrolidone, 12.0kg of 6-chloro-3-methyluracil and 10.77kg of N,N-diisopropylethylamine into a 300L glass-lined reactor, and stir until dissolved.

[0110] (2) Add 12.24 kg of 2-cyanobenzyl bromide into the reaction kettle, stir to dissolve.

[0111] (3) Heat the reaction kettle to 60-65°C, stir and keep warm for 3 hours; start TLC monitoring after 3 hours until the reaction ends, that is, the raw material point of 6-chloro-3-methyluracil basically disappears; take samples for monitoring every 0.5 hours.

[0112] The reaction endpoint monitoring method is as follows.

[0113] ①Preparation of the test solution: take about 0.2ml of the reaction solution, add 2ml of N-methylpyrrolidone to dilute, and obtain the product.

[0114] ②Preparation of the control solution: Take about 2mg of 6-chloro-3-methyluracil, add 2ml of N-methylpyrrolidone to dissolve it.

[0115] ③ Chromato...

Embodiment 3

[0157] The first step is to prepare the alogliptin intermediate AGI.

[0158] (1) Add 29.0kg of N-methylpyrrolidone, 16.0kg of 6-chloro-3-methyluracil and 17.36kg of N,N-diisopropylethylamine into a 300L glass-lined reactor, and stir until dissolved.

[0159] (2) Add 16.32 kg of 2-cyanobenzyl bromide into the reaction kettle, and stir to dissolve.

[0160] (3) Heat the reaction kettle to 60-65°C, stir and keep warm for 3 hours; start TLC monitoring after 3 hours until the reaction ends, that is, the raw material point of 6-chloro-3-methyluracil basically disappears; take samples for monitoring every 0.5 hours.

[0161] The reaction endpoint monitoring method is as follows.

[0162] ①Preparation of the test solution: take about 0.2ml of the reaction solution, add 2ml of N-methylpyrrolidone to dilute, and obtain the product.

[0163] ②Preparation of the control solution: Take about 2mg of 6-chloro-3-methyluracil, add 2ml of N-methylpyrrolidone to dissolve it.

[0164] ③ Chrom...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to an industrial production method of Alogliptin benzoate, and belongs to the technical field of industrial pharmacy. The method comprises three steps of 1, preparing an Alogliptin intermediate AG I; 2, preparing an Alogliptin intermediate AG II; 3, preparing the Alogliptin benzoate. The industrial production method has the beneficial effects that the reaction conditions areproper; the operation is simple and convenient; the realization is easy; only the Alogliptin intermediate AG II is prepared; then, the AG II and benzoic acid are subjected to tetrahydrofuran synthesis; the Alogliptin benzoate can be obtained; the process is saved; the cost is reduced; used solvents have small environment pollution; the operation is safe; under the large-scale industrial productioncondition, the existing average yield is only about 30 percent; under the condition that the final yield reaches 19.32kg, the finial product yield reaches 94.77 percent; the total yield reaches 60.11percent; high quality and purity can be maintained; the production efficiency is greatly improved.

Description

technical field [0001] The invention belongs to the technical field of industrial pharmacy, in particular to an industrial production method of alogliptin benzoate. Background technique [0002] Alogliptin benzoate, chemical name: 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2 ,4-dioxo-1(2H)-pyrimidinyl]methyl]benzonitrile benzoate, its form is white or off-white crystalline powder. Soluble in dimethyl sulfoxide, soluble in methanol, slightly soluble in water, slightly soluble in ethanol. Its molecular formula is: C 18 h 21 N 5 o 2 .C 7 h 6 o 2 , Molecular weight: 461.51. The chemical structure is as follows. [0003] . [0004] Alogliptin benzoate is a highly selective inhibitor of the serine protease dipeptidyl peptidase IV (DPP-IV), maintaining glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide in vivo (GIP) levels, promote the secretion of insulin, thereby exerting a hypoglycemic effect. [0005] For the industriali...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07D401/04C07C63/06C07C51/41
CPCC07D401/04
Inventor 罗庆林宋绍华龚胡荣
Owner NANHAI PHARMA CHONGQING
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap